Diabetes and colorectal cancer | Tinnitus

Anti-diabetes drugs may reduce risk of colorectal cancer; cochlear nerve damage associated with tinnitus; tracking organ aging and disease

Having trouble viewing this email? View it as a Web page.

January 9, 2024 Edition

Man sitting on couch and preparing a GLP-1RA injection.

Anti-diabetes drugs may reduce the risk of colorectal cancer

People with diabetes who took drugs called GLP-1 receptor agonists had a lower risk of colorectal cancer compared with those prescribed other diabetes drugs.

Young Black man touching his ear in distress.

Cochlear nerve damage associated with tinnitus

People with chronic tinnitus were more likely to have signs of damage to their cochlear nerve than people without the condition.

Scientists hands labelling a test tube while another researcher in the background looks through a microscope.

Tracking organ aging and disease

Researchers found that proteins in the blood can be used to track the aging of individual organs, and that faster organ aging increased the risk of disease and death.

Connect with us:

Facebook

RSS Feed

Update Your E-mail Address | Add Subscriptions | Unsubscribe All

If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact Ask NIH. Before writing, please view ourFrequently Asked Questions page, our Health Information page, or Search our website.

This service is provided to you by the National Institutes of Health.
NIHTurning Discovery Into Health

This email was sent to newsletter@newslettercollector.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) 9000 Rockville Pike Bethesda MD 20892 301-496-4000 / TTY 301-402-9612

January 9, 2024 Edition

Anti-diabetes drugs may reduce the risk of colorectal cancer

Cochlear nerve damage associated with tinnitus

Tracking organ aging and disease

Popular Stories:

Connect with us: